| 1 |
Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations
Lou WJ, Stimple SD, Desai AA, Makowski EK, Kalyoncu S, Mogensen JE, Spang LT, Asgreen DJ, Staby A, Duus K, Amstrup J, Zhang YL, Tessier PM
Biotechnology and Bioengineering, 118(2), 797, 2021 |
| 2 |
Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway
Han X, Ding CH, Zhang GD, Pan RY, Liu YP, Huang N, Hou NN, Han F, Xu WJ, Sun XD
Biochemical and Biophysical Research Communications, 525(4), 895, 2020 |
| 3 |
Liraglutide promotes the angiogenic ability of human umbilical vein endothelial cells through the JAK2/STAT3 signaling pathway
Di YB, He J, Ma P, Shen N, Niu CH, Liu X, Du XM, Tian FS, Li HM, Liu Y
Biochemical and Biophysical Research Communications, 523(3), 666, 2020 |
| 4 |
Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway
Li Z, Feng PP, Zhao ZB, Zhu W, Gong JP, Du HM
Biochemical and Biophysical Research Communications, 510(1), 20, 2019 |
| 5 |
Protective effect of the glucagon-like peptide-1 analogue liraglutide on carbon tetrachloride-induced acute liver injury in mice
Zhang WY, Hu XF, Wan N, Zhang JF, Yang P, Wen Q, Chen WJ, Zhu F, Liang ML, Cheng LX, Shu YW
Biochemical and Biophysical Research Communications, 514(2), 386, 2019 |
| 6 |
Sustained release and pharmacologic evaluation of human glucagon-like peptide-1 and liraglutide from polymeric microparticles
Icart LP, de Souza FG, Lima LMTR
Journal of Microencapsulation, 36(8), 747, 2019 |
| 7 |
Liraglutide Immobilized on Poly(lactic-co-glycolic acid) Polymer Films Induced the Differentiation of Islet β-Like Cells from Bone Marrow Mesenchymal Stem Cells
Sun S, Cui W, Dong Y, Wang Q
Macromolecular Research, 27(5), 454, 2019 |
| 8 |
Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells
Chen A, Chen ZW, Xia Y, Lu DB, Yang XD, Sun AJ, Zou YZ, Qian JY, Ge JB
Biochemical and Biophysical Research Communications, 499(2), 267, 2018 |
| 9 |
GLP-1 receptor agonist liraglutide exerts central action to induce beta-cell proliferation through medulla to vagal pathway in mice
Kumari P, Nakata M, Zhang BY, Otgon-Uul Z, Yada T
Biochemical and Biophysical Research Communications, 499(3), 618, 2018 |
| 10 |
Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet
Zhu W, Feng PP, He K, Li SW, Gong JP
Biochemical and Biophysical Research Communications, 505(2), 523, 2018 |
